COM RESEARCHERS DATABASE

Thematic Area : Malaria

Study Title Investigator
SMAC (Severe Malaria in African Children Network) Artesunate Follow-up Study: Comparative Taylor Terrie Ellen Prof
Pharmacological modelling and data analysis in decision support of antimalarial drug dosing regimens Terlouw Dianne Janette (Anja) Dr
"Special populations and label expansion studies with the fixed dose combinations artemether-lumefantrine Terlouw Dianne Janette (Anja) Dr
Cluster-randomized cohort study to assess the safety and effectiveness of combination therapies in repeated treatments for uncomplicated P.falciparum malaria over a three year period (ACTia). Terlouw Dianne Janette (Anja) Dr
Development of age and weight based dose regimens for a new fixed-dose artesunate-mefloquine combination for uncomplicated falciparum malaria. Terlouw Dianne Janette (Anja) Dr
CDC-LSTM 5 year Cooperative agreement (2005-2010) to conduct applied research to identify and evaluate interventions for the control of malaria across a range of malaria transmission settings in Africa and Asia. Terlouw Dianne Janette (Anja) Dr
"Rapid assessment of the burden of malaria in pregnancy in Madhya Pradesh Terlouw Dianne Janette (Anja) Dr
Age and height based dosing of antimalarials as a proxy for dosing based on bodyweight. Terlouw Dianne Janette (Anja) Dr
Program evaluation of the 2004 Togo integrated National Child Health Campaign: impact on malaria morbidity in children less than 5 years. Terlouw Dianne Janette (Anja) Dr
Evaluation of easy access groups as a tool for monitoring temporal changes in malaria transmission in Malawi: The EvalMal study. Sesay Sanie S.S. Dr
A trial of intermittent preventive treatment and home based management of malaria in a rural area of The Gambia. Sesay Sanie S.S. Dr
Efficacy and safety of a new fixed-dose oral combination of pyronaridine/artesunate versus artemether/lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria. The PYRAMAX Trial Phase I and II. Sesay Sanie S.S. Dr
Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia. Sesay Sanie S.S. Dr
Surviellance for antimalarial drug resistance in Malawi Ugaz J. Dr
Effect of ART and role of compartmentalization Everett Dean Dr
Phenotypic and genotypic characterisation of invasive clincial isolates os S. pneumoniae from 2009-2013. Tembo Dumizulu Dr
Phenotypic and genotypic characterisation of invasive clincial isolates os S. pneumoniae from 1996-2008 Tembo Dumizulu Dr
Investigation of differential expression of var gene groups and identification of crucial host-parasite interactions in the organs of fatal falciparum malaria patients Ocholla Harold Dr
Investigating of Differential Expression of var gene Groups and Identification of Crucial host-parasite Interactions in the Organs of Fatal Falciparum Malaria Patients Ocholla Harold Dr
Genome-wide Variation and a Map of Genetic Diversity in Plasmodium Falciparum Joaquin Miguel San Dr
Genome-wide variation and a map of genetic diversity in plasmodium falciparum Joaquin Miguel San Dr
Dysregualtion of Coagulation in Malaria Mzinza D. Dr
Functional investigation of plasmodium falciparum var genes expressed at high levels in the tissues of Malawian paediatric malaria patients Maleta Towera Mrs
The visual and visuomotor function in cerebral malaria survivors Chipwete S.E. Dr
A Phase III open label, randomized, multicenter trial to assess the efficacy and safety of the dispersible arterolane maleate 37.5 mg and piperaquine phosphate(PQP) 187.5 mg tablets in comparison with Coartem® dispersible in pediatric patients with acute uncomplicated Plasmodium falciparum malaria Mwapasa Victor Prof
Special populations and label expansion studies with fixed dose combinations artemether-lumefantrine, amodiaquine-artesunate, and dihydroartemisinin-piperaquine in Zambia, Malawi and Mozambiqu Mwapasa Victor Prof
Saving Brains: New malaria policies to protect early brain development (Award #0343-03) Mwapasa Victor Prof
Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria Mwapasa Victor Prof
Optimization of the existing dose and regimen of intermittent preventive treatment with sulphadoxine-pyrimethamine for the prevention of malaria in pregnancy in the context of high coverage of insecticide-treated nets and highly seasonal malaria Mwapasa Victor Prof
The Effect of Pregnancy Associated Malaria on Early Childhood Neurocognitive Development Madanitsa Mwayi Dr
Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial. Madanitsa Mwayi Dr
Control of malaria in pregnancy with scheduled intermittent screening with rapid diagnostic tests and treatment with dihydroartemisinin-piperaquine versus intermittent preventive therapy with sulfadoxine-pyrimethamine in Malawi: a randomized clinical trial. Madanitsa Mwayi Dr
Vascular Dysfunction in the Pathogenesis of Severe Malaria Taylor Terrie Ellen Prof
Determinants of Malaria Disease in Malawi Taylor Terrie Ellen Prof
Anopheles Infection by Asymptomatic Gametocytemic Humans: Hidden Malaria Dynamics Taylor Terrie Ellen Prof
Intersectoral Fellowships on Irrigated Agriculture and Human Health in Malawi Taylor Terrie Ellen Prof
Rapid in-field malaria diagnosis, prognosis and monitoring using a mobile phone Taylor Terrie Ellen Prof
Clinicopathological and Magnetic Resonance Imaging Correlates of Cerebral Malaria Taylor Terrie Ellen Prof
Towards Noninvasive Diagnostics of Malaria Infection Through Exhaled Breath Analysis Trehan Indi Dr
ADJusT Trial Khuluza Felix Mr
Quality of Antimalarial and antibiotic medicines in Malawi (QAAM) Khuluza Felix Mr
Intensified HIV/TB prevention linking home-based HIV testing including the option of self-testing with HIV care: A cluster randomized trial in Blantyre, Malawi Corbett Elizabeth Dr
Epidemiology of malaria in Malawi: Human hosts and parasites in three districts: Part 1 facility-based surveillance Laufer Mirriam Dr
Effect of text messages on health worker's adherence to malaria and other disease case management guidelines in Malawi Mathanga Don Pascal Dr
Demographic Survey and Health facility assesment of the Majete Parameter, Southern Malawi Phiri Kamija Prof
Efficancy and Safety of Artether-lomefantrine and co-formulated Artesanate-amodiaquine for the treatment of uncomplicated plasmodium falciparum malaria in Mangochi District Mathanga Don Pascal Dr
Efficancy and Safety of Artether-lomefantrine and co-formulated Artesanate-amodiaquine for the treatment of uncomplicated plasmodium falciparum malaria in Mangochi District Mathanga Don Pascal Dr
Investigation of Parasite Receptors on Infected Red Blood Cells Mphande Fingani Dr
Dysregulation of coagulation in Malaria Moxon C. Dr
Genome-wide Variation and a map of genetic diversity in Plasmodium Falciparum Ocholla Harold Dr
Intra-host dynamics of co-infecting parasite genotypes in malaria patients- a cross sectional study. Nkhoma Chinura Standwell Dr
Intra-host dynamics of co-infecting parasite genotypes in malaria patients- a longitudinal study. Nkhoma Chinura Standwell Dr
The Social and Cultural Context of Malaria in Pregnancy (MiP) in Blantyre and Chikwawa Districts in Malawi Manda-Taylor Lucinda Dr
Safe and efficacious artemisinin-based combination treatments for African pregnant women with Malaria . Chapotera Getrude Dr
A phase 3, open label, randomized, comparative study to evaluate Azithromycin plus Chloroquine and sulfadoxine plus pyrimethamine combinations for intermittent preventive treatment of falciparum malaria infection in pregnant women in Africa: A0661158 study. Phiri Kamija Prof
Severe Anaemia in African children. Phiri Kamija Prof
Intermittent Preventive Therapy post-discharge (IPTpd). Phiri Kamija Prof
Control of malaria in pregnancy with scheduled intermittent screening with rapid diagnostic tests and treatment with dihydroartemisinin-piperaquine versus intermittent preventive therapy with sulfadoxine-pyrimethamine in Malawi: a randomized clinical trial. Madanitsa Mwayi Dr
Determinants of malaria disease in Malawi. Mwandumba H. Dr
A Dose-Sscalation, Safety and FeasibilityStudy of Enteral Levetiracetam for Seizure Control in Pediatric Cerebral Malaria Mallewa Macpherson Assoc
Improving the impact of existing Malaria Products - ACTs. Terlouw Dianne Janette (Anja) Dr
Malawi-Liverpool-Wellcome Trust Clinical Research Programme. Maleta Kenneth Prof
Insectcide-treated net effectiviness in a setting of significant pyrethroid resistance: a case control study of children 6-59 months old in Machinga district, malawi. Mathanga Don Pascal Dr
Clinicopathological and Magnetic Resonance Imaging Correlates of Cerebral malaria. Kamiza Steve Bvuobvuo Assoc
A SIM card-based disposable biosensor for rapid malaria detection Lillehoj B. Peter Prof
Pathogenesis of cognitive/neurologic deficits in central nervous system malaria. McDermott Michael P. Prof
Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria Joshi Vinayak Dr
Wrong parasite wrong host? How plasmodium falciparumErythrocyte Membrane Protein 1 expression and the hosts' innate immunity combine to influence the inflamatory response to malaria. Mandala Wilson Lewis Dr
Using MRI technology in Zambia and Malawi to Gain Insights into Mechanisms of Brain Injury and Dysfunction in Pediatric Cerebral Malaria Kampondeni Sam Dr
The Retinal Microvasculature in Cerebral Malaria in African Children Kampondeni Sam Dr
Clinicopathological and Magnetic Resonance Imaging Correlates of Cerebral Malaria Potchen J. Michael Prof
Effects of malaria control interventions on malaria transmission Cohee Lauren Dr
Determinants of Malaria Disease in Malawi Cohee Lauren Dr
Malaria in School-Age Children: Defining new interventions to improve health and reduce transmission Cohee Lauren Dr
Reaching all children through school-based interventions Cohee Lauren Dr
What are we missing? Malaria infection, disease and transmission in school-age children Cohee Lauren Dr
Determinants of Malaria Disease in Malawi Daily Johanna Patricia Assoc
International Centres of Excellence for malaria. Seydel Boynton Karl Prof
A Dose Escalation, Safety and Feasibility Study of Enternal Levetiracetam for Seizure Control in Paedriatic Cerebral malaria. Seydel Boynton Karl Prof
Role of Type I IFN during mild Plasmodium Falciparum infection and association with clinical diseases in Malawi. Seydel Boynton Karl Prof
HRP-2 as a predictor of malaria severity. Seydel Boynton Karl Prof
Anopheles infection by Assymptomatic Gametocytemic Humans: Hidden malaria dynamics Seydel Boynton Karl Prof
Vaccines Against Malaria Laurens B. Matthew Assoc
Larval Mosquito Feeding and Microbial Interactions Walker D. Edward Prof
Determinants of Malaria Disease in Malawi Walker D. Edward Prof
Intersectoral Fellowships on Irrigated Agriculture and Human Health in Malawi Walker D. Edward Prof
Asymptomatic Gametocytemia and Malaria: Implications for Plasmodium Transmission Walker D. Edward Prof
Interdisciplinary malaria research training in Malawi Walker D. Edward Prof
Contributors to coma in retinopathy negative cerebral malaria Postels George Douglas Assoc
Neurodevelopmental outcomes in severe malaria Postels George Douglas Assoc
A Dose-Escalation, Safety and Feasibility Study of Enteral Levetiracetam for Seizure Control in Pediatric Postels George Douglas Assoc
Determinants of Malaria Disease in Malawi Wilson L. Mark Prof
Intersectoral Fellowships on Irrigated Agriculture and Human Health in Malawi Wilson L. Mark Prof
Optimizing resource allocation across multiple interventions for cost-effective malaria prevention and control Wilson L. Mark Prof
Importance of Unrecognized Plasmodium Infection: Low-Density Gametocyte Carriage and Malaria in Malawi Wilson L. Mark Prof
Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi Kayange Cyrus Petros Dr
The Effect of Daily Co-Trimoxazole Prophylaxis on Natural Development of Antibody-Mediated Immunity against P. falciparum Malaria Infection in HIV-Exposed Uninfected Malawian Children Mbeye Nyanyiwe Dr
The Effect of Daily Co-Trimoxazole Prophylaxis on Natural Development of Antibody-Mediated Immunity against P. falciparum Malaria Infection in HIV-Exposed Uninfected Malawian Children Mbeye Nyanyiwe Dr
The Effect of Daily Co-Trimoxazole Prophylaxis on Natural Development of Antibody-Mediated Immunity against P. falciparum Malaria Infection in HIV-Exposed Uninfected Malawian Children Jambo Kondwani Charles Dr
Improving access to malaria prevention and treatment, and surveillance in rural Malawi Kabaghe Alinune Dr
malaria research focusing on epidemiology entomology, community engagement and behavioral change and health system strengthening Kabaghe Alinune Dr
Evaluation Protocol: LINK, Data for malaria control decision-making project Malawi study Mipando-Nyondo Linda Dr
IPTp with dihydroartemisinin-piperaquine and azithromycin for malaria, sexually transmitted and reproductive tract infections in pregnancy in high sulphadoxine-pyrimethamine resistance areas in Kenya, Malawi and Tanzania Madanitsa Mwayi Dr
Maximising the public health impact of interventions to control malaria in pregnancy through the transmission of EDCTP-funded evidence-based global policies to country level policies and Madanitsa Mwayi Dr
Strengthening National Capacity in Malaria and other infectious disease operations Mathanga Don Pascal Dr
Determinants of Malaria Disease in Malawi Mathanga Don Pascal Dr
Interdisciplinary malaria research training in Malawi Mathanga Don Pascal Dr
“Impact of malaria during pregnancy on infant health Mathanga Don Pascal Dr
The Intransigence of Malaria in Malawi: Understanding Hidden Reservoirs, Successful Vectors, and Prevention Failures. Mathanga Don Pascal Dr
An evaluation in Malawi of the cluster-randomized RTS/AS 01 Malaria Vaccine Implementation Pilot (MVIP) through routine health systems in moderate to high malaria transmission settings in Sub-Saharan Africa Mathanga Don Pascal Dr